Skip to content

Respiratory Effects of Dopamine in the Perioperative Care

Respiratory Effects of Dopamine in the Perioperative Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04753008
Acronym
DOPHUMAN
Enrollment
100
Registered
2021-02-12
Start date
2010-12-13
Completion date
2021-12-31
Last updated
2021-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchodilation, Dopamine, Functional Disturbance, Heart, Surgery

Brief summary

Dopamine is frequently used as an inotropic drug to elevate cardiac output. In addition to the beneficial cardiac effect of this drug, the few previous studies addressing its ability to alter the airway tone reported controversial results. Thus, the investigators aimed at clarifying the potential of dopamine to alter gas exchange outcomes and the airway tone in patients undergoing cardiac surgeries with cardiopulmonary bypass. Blood gas parameters, airway resistance, tissue damping and tissue elastance will be measured in the patients before the CPB, immediately after CPB, and 5 min after administration of dopamine (3 mcg/kg/min). The importance of the research is to reveal whether the beneficial mechanical changes after dopamine administrations are associated with improvements in gas exchange outcomes. Clarification of this research question have scientific relevance and may also improves patient outcomes.

Interventions

Administration of dopamine (3 mcg/kg/min) as part of cardiac support therapy after the cardiopulmonary bypass. Administration of dopamine is a subject of clinical decision based on the cardiovascular status of the patients.

Sponsors

Szeged University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Cardial surgery patients undergoing cardiopulmonary bypass procedures

Exclusion criteria

* Chronic respiratory diseases, elderly (\>80 years)

Design outcomes

Primary

MeasureTime frameDescription
Arterial oxygen partial pressure (PaO2)5 min after administration of dopaminePartial pressure of oxygen in the blood sample assessed by a blood gas analyser.
Arterial carbon dioxide partial pressure (PaCO2)5 min after administration of dopaminePartial pressure of carbon dioxide in the blood sample assessed by a blood gas analyser.
Lung mechanics5 min after administration of dopamineAirway resistance, lung tissue damping and lung tissue elastance obtained by forced oscillation technique.

Secondary

MeasureTime frameDescription
Capnography5 min after administration of dopamineTime capnography to obtain phase 3 and phase 2 slopes.
Intrapulmonary shunt5 min after administration of dopamineIntrapulmonary shunt obtained by the Berggren shunt equation from arterial and central venous blood samples.

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026